chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No additional AE; expired MMR-II was administered; This spontaneous report was received from a vaccine administrator refers to a patient of unknown age and gender. No information was provided regarding the patient's medical history, historical drugs, allergies and concurrent conditions. No concomitant therapies were reported.     On 14-DEC-2021, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), 5 ml (route of administration and indication were not provided), lot # S039313 and expiration date since it make matches with the autopopulated expiration date 04-DEC-2021. No additional adverse event was reported.
Patient began having arm/shoulder blade pain the day of vaccination.  She experienced limited mobility and began treating with OTC analgesics.  She has exhibited steady improvement over the course of the past few days.  She has not contacted her PCP, but will if she does not continue to show improvement.
Pain at injection site hasn?t gone away from my 2nd dose on 2/11/2021 to today 3/31/2021
itching starting at the injection site going up the left shoulder; itching starting at the injection site going up the left shoulder; feel a slight rough texture to the skin on her arm at the area of the itching; this has spread across the back of her neck to her other shoulder; itchy, red, bumpy, hot rash; itchy, red, bumpy, hot rash; itchy, red, bumpy, hot rash; itchy, red, bumpy, hot rash; This is a spontaneous report from a contactable consumer or other non hcp (Patient).   A 54-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EP7534, expiration date: not reported) via an unspecified route of administration, administered in left arm on 19Mar2021 at 17:00 (at the age of 54-years-old) as dose 1, single for covid-19 immunization. Medical history included Gastric Sleeve Surgery from an unknown date and unknown if ongoing Verbatim: Gastric Sleeve Surgery, sinus, allergies, AV Node reentry and tachycardia, nerve pain fibromyalgia, COPD and Depression, start and stop date unknown. Patient had no family history. Concomitant medication(s) included gabapentin (GABAPENTIN) taken ongoing, 400mg; take one four times a day by mouth taking 8 years for nerve pain fibromyalgia; montelukast (MONTELUKAST) taken ongoing 10mg; take once daily by mouth, taking 4 years for allergies; diltiazem hydrochloride (CARTIA XT) taken ongoing, 120mg; take once daily by mouth, taking 4 years for AV Node reentry and tachycardia; fluticasone propionate (FLUTICASONE PROPIONATE) taken ongoing, two sprays each nostril once daily, using four years for allergies; bupropion hydrochloride (BUPROPION HCL XL) taken ongoing, 150mg; take one twice daily by mouth, taking for 2 years for Depression; cetirizine hydrochloride (CETIRIZINE HYDROCHLORIDE) taken ongoing, 10mg; take once daily by mouth, taking for 6 months for sinus; tiotropium bromide (SPIRIVA) taken ongoing, 18mcg; take once daily by mouth, taking for 8 years for COPD; salbutamol sulfate (PROAIR HFA) taken ongoing, inhaler use as needed, taking for 8 years for COPD and Multivitamin taken ongoing taking for three years. History of all previous immunization with the Pfizer vaccine considered as suspect was none. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. No Prior Vaccinations (within 4 weeks). On 20Mar2021, patient experienced itching starting at the injection site going up the left shoulder, feel a slight rough texture to the skin on her arm at the area of the itching; this has spread across the back of her neck to her other shoulder, itchy, red, bumpy, hot rash. The outcome of all events were not recovered.   No follow up attempts are possible. Information about lot/batch number cannot been obtained.
Initial unsolicited report received from a consumer on 25-JUL-2017. This case involves a 70-year-old female patient who was vaccinated with a dose of INFLUENZA VACCINE (FLU SHOT) (batch number, expiry date, dose, dose in series, route and site of administration were not reported) on an unspecified date. Patient's medical history and concomitant medications included ALIROCUMAB (praluent) (injections, batch number: 7F076A, expiry date: 30-JUN-2018, dose in series, route and site of administration were not reported) for cardiovascular disorder (reported as 'Patient has taken 6 Praluent injections and had no issues with the first 5, but with the most recent one, experienced a red welt, unable to tolerate statins'). On an unspecified date, following the vaccination, the patient was unable to move her arm for a week. Lab data and corrective treatment were not reported. On an unspecified date, the patient recovered from the event. List of documents held by sender: none.
PNEUMOVAX administered right deltoid 4/21/09 after leaving office, pt started to develop pain in right upper arm. During rest of day and night, pain increased to involve right upper arm from elbow to shoulder - no redness or local heat - "felt like bursitis" used TYLENOL , local heat pain started to decrease 4/22/09.
Anthrax (4086) & Typhoid given in left arm. Within 24 hrs arm swollen from upper bicep to below elbow. Skin red & hot to touch. Symptoms present after 72 hrs.
This spontaneous report as received from a pharmacist refers to a 68 years old female patient without pertinent medical history and no drug reactions. The patient was vaccinated with 0.65 ml ZOSTAVAX (lot number reported as H013021, expire date unspecified) subcutaneously on 20-OCT-2012. No other co-suspects were reported. There was no concomitant medication. The patient who received ZOSTAVAX on 20-OCT-2012 came down with shingles. The patient saw her physician (name unspecified) on 22-OCT-2012 and was diagnosed with shingles and received prescription for VALTREX. No diagnostics studies were performed. The outcome of shingles was unknown. Additional information has been requested.
Left under arm, armpit and breast tissue swelling.  Site of injection has 50 cent piece size redness and hard swollen area around the redness.  All symptoms were noticed the following morning after receiving the booster and have continued through today, 3 days after receiving the injection.
Pt developed generalized urticaria and mild throat swelling within 24 hours of vaccine administration, symptoms gradually resolved over next 12-24 hours.
Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Vomiting-Medium
Failed Vaccine 8/7/06 Received death certificate which revealed COD as streptococcal pneumoniae sepsis with underlying cause of streptococcal pneumoniae pneumonia. 8/11/06 Received D/C summary from hospital which reveal patient was hospitalized from 5/19/06-5/22/06 with bilateral pneumonia, hypotension, chronic CHF, acute mental status changes, hx of CAD & pulmonary embolism for which patient had recently d/c Coumadin and chronic abdominal pain.  Final dx: bilateral streptococcal pneumoniae pneumonis; sepsis secondary to streptococcus pnaumoniae; acute renal failure; MI on 5/21/06; hypotension;acute mental status change; & chronic abdominal pain.  Patient's clinical status worsened progressively until her death despite antibiotics, IVF & Dopamine & O2 by mask.
Patient reported to Pharmacist after 5 minutes after having Moderna  Injection she was not feeling well. She looked very panic I sat with her and she explained she was having numbness in hands  and chest . She was not having difficulty breathing so I did not give  her an epi pen injection.   WE talked and after 5 minutes I asked if she would like a benadryl 50mg injection  She said yes because she was not getting better.  She was getting very anxious 5 minutes later I asked her if she wanted to call 911   The staff did so .  Paramedics  arrived in 10 minutes lThey gave her oxygen and started an IV   Her blood pressure was elevated .   She was taken to nearby hospital  .  Paramedic stated I did the right thing by calling and that she had been hyperventalating  which can cause numbness in chest and hands
pain immed upon recv vax in lt arm;pain got sl worse w/each day;eventually consulted personal MD;provided pain med which helped some;painful to raise;lt hand got numb;pain in neck & back lt side;
immediately following vaccine, patient reported left palm turning purple and left foot/ankle numbness. Symptoms persisted x 15 minutes.
Patient stated she has a knot on her left arm. Itching and warmth at knot. The knot is a little painful. Saw PCP. Her doctor said it appeared to be a delayed reaction to vaccination.
I had fatigue a few hours after second dose, after that I had dehydration symptoms such as headache, chills, body aches fever, nausea, all overnight, next morning went away by midday.
After I got the vaccine, I have now noticed a dent in my arm from where I got the vaccine from. There is a small, red scar, and the dent goes far into my muscle. It feels like there is no muscle there anymore. If I press on it for too long it starts to hurt.
Recent Allergic reaction to latex products which consisted of a skin rash from neck to chest. I have not had a reaction to these same products in the past twenty years. Now I am covered with a skin rash.
Location of vaccine shot still pink and slightly painful almost a month after shot.  Breathing difficulty 3 days after shot was resolved using Benadryl.
Found dead; Felt crappy; Wasn't feeling well; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of DEATH (Found dead) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal ("Patient was on blood pressure medications for the last 20 years") and Anticoagulant therapy ("Patient started on a blood thinner in January 2021").   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced FEELING ABNORMAL (Felt crappy) and MALAISE (Wasn't feeling well). On 18-Apr-2021, FEELING ABNORMAL (Felt crappy) and MALAISE (Wasn't feeling well) outcome was unknown. The patient died on 18-Apr-2021. The cause of death was not reported. It is unknown if an autopsy was performed. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  The patient was on blood pressure medications (unspecified) for the last 20 years. She was started on blood thinner (unspecified) in January 2021.  Treatment information leading up to the patient's death was not reported.  Action taken with mRNA-1273 in response to the events was not applicable.  A case of death of a 75-year-old, female patient 3 days after the second dose of mRNA-1273 (Lot # 040A21A).  Patient had developed abnormal feeling and malaise 2 days after vaccine use and based on temporal association cannot be excluded.  However, causality cannot be established for the death as cause of death is unknown.  Further information is being requested.; Sender's Comments: A case of death of a 75-year-old, female patient 3 days after the second dose of mRNA-1273 (Lot # 040A21A).  Patient had developed abnormal feeling and malaise 2 days after vaccine use and based on temporal association cannot be excluded.  However, causality cannot be established for the death as cause of death is unknown.  Further information is being requested.; Reported Cause(s) of Death: Found dead
Runny nose, lethargy, low-grade fever of 101 degrees. On 12/21/11, two household members also began to suffer the same symptoms. Symptoms continued in everyone for 2- 3 days.
patient was 17 and not eligible. Lead Provider advised  waited 30 minutes w/o incident. guardian advised of error and ineligible for second dose now.
Redness and swelling of left upper arm (where the injection was placed). Improved with motrin and benadryl; also swelling of auricle / helix on that side as well (ear), but suspect it was secondary to mosquito bite and not related to the vaccine (the EAR); in terms of the swelling at the site of the injection, mother reports this happened last year as well, but it was not as pronounced
shingles in left leg, having symptoms again; severe pain in leg; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (11 years ago).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles and leg pain. On an unknown date, the outcome of the shingles and leg pain were unknown.   It was unknown if the reporter considered the shingles and leg pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient had a very bad case of shingles down my left leg. The patient received dose of Shingles vaccine and started having symptoms again a week and a half ago from reporting. The patient stated that the pain in his/her leg was as severe the shingles was 11 years ago. The patient was on a non-viral prescription and he/she could have the shot again. The patient could not wait to get that shot next week. The patient stated no Covid shot for him/her. The follow-up would not possible as no contact details were available.
Broken blood vessels all over white of left eye; Fatigue; A spontaneous report was received from a 59-year-old female patient , who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fatigue and broken blood vessels all over white of left eye/eye haemorrhage.  The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included atorvastatin and acetylsalicylic acid (low dose).  On 10 Mar 2021, prior to the onset of events, the patient received their first of two planned doses of mRNA-1273(Batch number: 010a21a) on left arm for prophylaxis of COVID-19 infection.  On 11 Mar 2021, after receiving mRNA-127, the patient experienced fatigue which lasted for 6 hours. On 12 Mar 2021, the patient experienced broken blood vessels all over white of left eye.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the event, fatigue was considered as resolved on 11 Mar 2021. The outcome of event broken blood vessels all over white of left eye was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2023, outcome "not recovered" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received Paxlovid treatment from 08Jul2023 to 12Jul2023 for COVID-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300251667 Same patient, different drug/ AE;
Facial hair turned white all of a sudden. I now see this happening on my arms and legs. Went to the health center, but they could not point out the cause for this reaction.
CRUSHING HEADACHE @ TEMPLES, HEAVY HEAD AS IN EXTREMELY TIRED, MILD CHILLS.  STAYED UNDER BLANKET & WATCHED TV, WENT TO BED AND FELT FINE.
No additional AE; HCP states that ROTATEQ vaccine, that underwent a supported temperature excursion, was administered to a patient on Dec 27, 2022.; This spontaneous report has been received from a nurse concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported.  On 27-DEC-2022, the patient was vaccinated with an improper stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # W010331, has been verified to be a valid lot number for rotavirus vaccine, live, oral, pentavalent, expiration date reported and upon internal validation established as 01-NOV-2023) (dose, anatomical location and route of administration were not reported) for prophylaxis. The vaccine underwent a temperature excursion (temperature: 8.9C, during 1 hour 49 minutes and 0 seconds) (Product storage error). The vaccine did not suffer previous temperature excursions.  No additional adverse events were reported.
03/16/2021: Presented to the emergency department with substernal chest pain/pressure. Patient was admitted for non-ST elevation MI, and currently awaiting cardiac catheterization.
Child noted to be scratching on pick up from day care the following day. Rash noted to trunk from nipple line to knees with lot of redness to groin. Afebrile. Took to ER via EMS on 2/2/2011 and discharged home with diphenhydramine. Rash seen by me on 2/4/2011 and is almost completly resolved. Eczema continues behind knee and legs.
Were down for 2 days after getting the vaccine; This is a spontaneous report received from a contactable reporter.  A patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "Were down for 2 days after getting the vaccine".  Additional Info:reported stated of 2 friends who were down for 2 days after getting the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Had a stroke. Shot to breakup blood clots, had a stint put in, had CAT scan, MRI and Ultrasound, had physical therapy and occupational therapy
Daughter has a temporary disability limiting her mobility. Meaning she walks with a cane. After vaccine she has reverted back to two canes and has nervous movements that now prevent her from being able to stand up without assistance or circulate well. She is receiving frequent doctor appointments to keep her spine aligned and has been placed in hyperbaric chamber to increase oxygen to her body. She is currently still experiencing difficulties with movement.
Swelling, pain, and heat at injection site beginning last night (12/29/20) around 9:00 pm.   Woke this morning with same plus very swollen and painful axilla to the same side.
Sweating; Throwing up; Fever; Splitting headaches; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), VOMITING (Throwing up), PYREXIA (Fever) and HEADACHE (Splitting headaches) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced HYPERHIDROSIS (Sweating), VOMITING (Throwing up), PYREXIA (Fever) and HEADACHE (Splitting headaches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Sweating), VOMITING (Throwing up), PYREXIA (Fever) and HEADACHE (Splitting headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
neuropathy; tingling in feet and legs; pain in legs; This serious case was reported by a nurse via sales rep and described the occurrence of neuropathy in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. In JAN-2023, an unknown time after receiving Shingrix, the patient experienced neuropathy (Verbatim: neuropathy) (serious criteria GSK medically significant), tingling of extremity (Verbatim: tingling in feet and legs) and leg pain (Verbatim: pain in legs). The outcome of the neuropathy, tingling of extremity and leg pain were unknown.   It was unknown if the reporter considered the neuropathy, tingling of extremity and leg pain to be related to Shingrix.     It was unknown if the company considered the neuropathy, tingling of extremity and leg pain to be related to Shingrix.   Additional Information: GSK Receipt date: 04-AUG-2023 The reporter is a Nurse Practitioner who informed GSK representative that a patient received Shingrix vaccine and "since January" the patients had experiencing neuropathy, tingling in feet and legs, also pain in legs.  The reporter consented to follow up. This case had been link with US2023AMR106712, reported by the same reporter.; Sender's Comments:  US-GSK-US2023AMR106712:Same reporter, different patient, same events
At approx 5:13pm on 1/21/2021, change in status with being unresponsive to conversation, Face flushed, taken no food for fluids for the day. T-101.5-102.3 pulse 88-100 02 sat 86%. Unable to take anything orally. Dr updated with request to be evaled in ER. Admitted  to rule out UTI, Covid test was negative, continued high temp, WBC count high.
At time of vaccine, developed fever, body aches, chills. Have been experiencing extreme fatigue now. It sure of it's related to the vaccine, or the virus which I had I. January or something else .